Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Vaccination with MAGE-3 Protein Can Induce a Potent Immune Response in a Healthy Donor Which Can Be Adoptively Transferred Via Stem Cell Transplant (Tx) to a Multiple Myeloma (MM) Patient.

Sacha Gnjatic, PhD, Susann Szmania, BS, Amberly Moreno, BS, M. Cottler-Fox, MD, John Shaughnessy, MD, Bart Barlogie, MD, PhD, Lloyd Old, PhD, Guido Tricot, MD, PhD, Frits van Rhee, MD, PhD

Blood (2005) 106 (11): 2197.

https://doi.org/10.1182/blood.V106.11.2197.2197

Published: 2005

Journal Articles

Killer Immunoglobulin-Like Receptor Ligand (KIR-Lig) Mismatched Natural Killer (NK) Cell Transfusions for Multiple Myeloma (MM).

J. Shi, MD, PhD, S. Szmania, BS, N. Rosen, BS, A. Moreno, BS, R. Walker, MD, B. DuPont, MD, K. Hsu, MD, L.A. Baxter-Lowe, PhD, J. Shaughnessy, PhD, B. Barlogie, MD, PhD, M. Cottler-Fox, MD, G. Tricot, MD, PhD, F. van Rhee, MD, PhD

Blood (2005) 106 (11): 3472.

https://doi.org/10.1182/blood.V106.11.3472.3472

Published: 2005

Journal Articles

Retroviral Gene Transduction of Adult Peripheral Blood or Marrow-Derived CD34 + Cells for Six Hours Without Growth Factors or on Autologous Stroma Does Not Improve Marking Efficiency Assessed In Vivo

R.V.B. Emmons, S. Doren, J. Zujewski, M. Cottler-Fox, C.S. Carter, K. Hines, J.A. O'Shaughnessy, S.F. Leitman, J.J. Greenblatt, K. Cowan, C.E. Dunbar

Blood (1997) 89 (11): 4040–4046.

https://doi.org/10.1182/blood.V89.11.4040

Published: 1997

Journal Articles

CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies

D Mavroudis, E Read, M Cottler-Fox, D Couriel, J Molldrem, C Carter, M Yu, C Dunbar, J Barrett

Blood (1996) 88 (8): 3223–3229.

https://doi.org/10.1182/blood.V88.8.3223.bloodjournal8883223

Published: 1996

Journal Articles

Transfer of the human glucocerebrosidase gene into hematopoietic stem cells of nonablated recipients: successful engraftment and long-term expression of the transgene

R Schiffmann, JA Medin, JM Ward, S Stahl, M Cottler-Fox, S Karlsson

Blood (1995) 86 (3): 1218–1227.

https://doi.org/10.1182/blood.V86.3.1218.1218

Published: 1995

Journal Articles

Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation

CE Dunbar, M Cottler-Fox, JA O'Shaughnessy, S Doren, C Carter, R Berenson, S Brown, RC Moen, J Greenblatt, FM Stewart

Blood (1995) 85 (11): 3048–3057.

https://doi.org/10.1182/blood.V85.11.3048.bloodjournal85113048

Published: 1995

Journal Articles

Ultraviolet B light inactivates bone marrow T lymphocytes but spares hematopoietic precursor cells

HJ Deeg, L Bazar, M Sigaroudinia, M Cottler-Fox

Blood (1989) 73 (2): 369–371.

https://doi.org/10.1182/blood.V73.2.369.369

Published: 1989

NARROW

Vaccination with MAGE-3 Protein Can Induce a Potent Immune Response in a Healthy Donor Which Can Be Adoptively Transferred Via Stem Cell Transplant (Tx) to a Multiple Myeloma (MM) Patient.

Killer Immunoglobulin-Like Receptor Ligand (KIR-Lig) Mismatched Natural Killer (NK) Cell Transfusions for Multiple Myeloma (MM).

Retroviral Gene Transduction of Adult Peripheral Blood or Marrow-Derived CD34 + Cells for Six Hours Without Growth Factors or on Autologous Stroma Does Not Improve Marking Efficiency Assessed In Vivo

CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies

Transfer of the human glucocerebrosidase gene into hematopoietic stem cells of nonablated recipients: successful engraftment and long-term expression of the transgene

Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation

Ultraviolet B light inactivates bone marrow T lymphocytes but spares hematopoietic precursor cells

Email alerts

ASH Publications

American Society of Hematology

Vaccination with MAGE-3 Protein Can Induce a Potent Immune Response in a Healthy Donor Which Can Be Adoptively Transferred Via Stem Cell Transplant (Tx) to a Multiple Myeloma (MM) Patient.

Killer Immunoglobulin-Like Receptor Ligand (KIR-Lig) Mismatched Natural Killer (NK) Cell Transfusions for Multiple Myeloma (MM).

Retroviral Gene Transduction of Adult Peripheral Blood or Marrow-Derived CD34 + Cells for Six Hours Without Growth Factors or on Autologous Stroma Does Not Improve Marking Efficiency Assessed In Vivo

CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies

Transfer of the human glucocerebrosidase gene into hematopoietic stem cells of nonablated recipients: successful engraftment and long-term expression of the transgene

Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation

Ultraviolet B light inactivates bone marrow T lymphocytes but spares hematopoietic precursor cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only